Medicinal Herbs and ADHD


Specialized Pro-Resolving Mediators and Omega-3s

August 5, 2019 • 3 min read

Specialized pro-resolving mediators are derived from omega-3 fatty acids eicosapentaenoic acid (EPA) and docosahexaenoic (DHA), and are vital for resolving inflammation.

Specialized pro-resolving mediators exist at the heart of the physiological response vital for resolving inflammation. Inadequate inflammation resolution builds a foundation for a plethora of chronic conditions, and thus fully understanding and appreciating the role of specialized pro-resolving mediators in homeostasis is critical for addressing these conditions. Specialized pro-resolving mediators are derived from omega-3 fatty acids eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA), and they include resolvins, maresins, protectins, and lipoxins.

What Are Specialized Pro-resolving Mediators?

Primarily, specialized pro-resolving mediators promote the resolution phase of inflammation, subsequently playing a role in host defense, organ protection, and tissue remodeling. They also initiate physiological changes at the inflammation site by ending neutrophil infiltration and by promoting macrophage uptake of apoptotic cells.1-2

Secondarily, these mediators keep pro-inflammatory mediators (e.g. eicosanoids, chemokines, and cytokines) in check, regulate specific microRNA activity, and enhance microbial killing.3-4

Why Care About Specialized Pro-resolving Mediators?

The resolution phase of inflammation prevents inflammation from turning into excessive chronic inflammation, leading to a variety of conditions like vascular disease, metabolic syndrome, and neurological diseases.1

Phases of Inflammation

Phase 1: Initiation Phase

Pro-inflammatory lipid mediators derived from polyunsaturated omega-6 arachidonic acid (ARA) and various cytokines and chemokines initiate inflammation.1 Lipid mediators, cytokines, chemokines, and complement components stimulate chemotaxis to move neutrophils into necessary tissues to break down and neutralize invaders through phagocytosis.1

Phase 2: Resolution Phase

Receptor antagonists resolve inflammation. Specialized pro-resolving mediators prevent neutrophils from continuing to enter tissues and promote macrophages to clear cellular debris.1 When inflammation resolution fails, inflammation will become excessive and chronic.1

Other Important Players

Prostaglandins and leukotrienes are eicosanoid pro-inflammatory lipid mediators important for vascular responses and neutrophils and monocytes exiting the circulation.1 Prostaglandins, along with leukotrienes, are produced from arachidonic acid (AA), and are necessary to activate the resolution phase of inflammation.5 Aspirin and nonsteroidal anti-inflammatory drugs (NSAIDs) inhibit prostaglandin biosynthesis, which in turn may inhibit the activation of the resolution phase.1

Microparticles are membrane-derived vesicles produced by self-resolving exudates, and they have anti-inflammatory and pro-resolving capacities.1 Microparticles also enhance macrophage clearing of debris during resolution and enhance specialized pro-resolving mediator biosynthesis.

M2 Macrophages are pro-resolving white blood cells that support specialized pro-resolving mediator production and engulf apoptotic neutrophils.3 Activation of macrophages is an essential step towards the resolution of inflammation.3 Eosinophils are white blood cells specific to parasitic infections and allergic responses, and they support specialized pro-resolving mediator production.1

Did you like this article?

  1. Serhan, C.N. (2014). Pro-resolving lipid mediators are leads for resolution physiology. Nature, 510(7503): p. 92-101.
  2. Maderna, P., Godson, C. (2009). Lipoxins: resolutionary road. Br J Pharmacol, 158(4): p. 947-59.
  3. Spite, M., Claria, J., Serhan, C.N. (2014). Resolvins, specialized proresolving lipid mediators, and their potential roles in metabolic diseases. Cell Metab, 19(1): p. 21-36.
  4. Li, Y., et al. (2013). Plasticity of leukocytic exudates in resolving acute inflammation is regulated by MicroRNA and proresolving mediators. Immunity, 39(5): p. 885-98.
  5. Ricciotti, E., FitzGerald, G. (2011). Prostaglandins and inflammation. Arterioscler Thromb Vasc Biol, 31(5): p. 986-1000.

Scientifically driven. Education focused. Healing Inspired.

Subscribe to Insights

Receive clinically driven nutrition insights you can trust.

Animated Newsletter WM

Join Our Community to Read Further

This is a premium article created for our Healthcare Practitioner readers. Create a free account to continue reading and gain full access.



WholisticMatters offers health care practitioners and nutrition enthusiasts alike the opportunity to create a free profile for access to site features like bookmarking. Enjoying an article you are reading or a video you are watching? Save it to come back to later! Sign up in seconds for continuous access to all that WholisticMatters has to offer.

WholisticMatters also offers health care practitioners who create a free user profile access to exclusive content and tools to utilize in clinical practice. Articles, tools, and downloads created specifically for practitioners to use in their office for better patient education in clinical nutrition and health. Sign up today with your email and credentials so we can confirm you as a health care practitioner, and you are free to peruse the resources unique to you and your colleagues in health.


Create Your Account:

show-pass Please use 8 or more characters with a mix of letters, numbers & symbols

Create a free account to use our great bookmarking tool

Once your account is created, you'll be able to save and organize what matters to you!

Already have an Account? Login Here

Click 'Sign Up' above to accept Wholistic Matters's Terms of Service & Privacy Policy.

Are you a Healthcare Professional? Sign Up For Free Access!

We'll verify your credentials and get you access to our great interactive tools.

Already have an Account? Login Here

Click 'Sign Up' above to accept Wholistic Matters's Terms of Service & Privacy Policy.